Rezolute RZLT
NASDAQ RZLT
$4.58 +0.04 (+0.88%)
As of: Sep 4, 2026 · 3:59 PM EDT

Rezolute (RZLT) Cash & Equivalents (2010 - 2026)

Rezolute (RZLT) posted Cash & Equivalents of $11.2 million for Q1 2026, down 6.23% sequentially from $11.9 million in Q4 2025, and down 23.29% YoY from $14.6 million in Q1 2025.

Analysis

Rezolute (RZLT) Cash & Equivalents (2010 - 2026) Analysis & Trends

Rezolute has reported Cash & Equivalents for 13 years, with the latest figure at $11.2 million in Q1 2026.

  • Quarterly Cash & Equivalents fell 23.29% year-over-year to $11.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.2 million (down 23.29% YoY) and the FY2025 annual result came in at $94.1 million, up 33.68% from the prior year.
  • Cash & Equivalents declined to $11.2 million in Q1 2026 per RZLT's latest filing, from $11.9 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $154.3 million in Q3 2022 and troughed at $5.9 million in Q1 2024.
  • A 5-year average of $48.3 million and a median of $14.6 million in 2025 frame the typical range for Cash & Equivalents.
  • The sharpest annual moves came in 2023 and 2024: Cash & Equivalents slumped 94.75% in 2023, then surged 338.99% in 2024.
  • Over 5 years, Cash & Equivalents stood at $146.7 million in 2022, then plunged by 91.48% to $12.5 million in 2023, then slipped by 28.57% to $8.9 million in 2024, then surged by 33.72% to $11.9 million in 2025, then decreased by 6.23% to $11.2 million in 2026.
  • According to Business Quant data, Cash & Equivalents over the past three periods registered $11.2 million, $11.9 million, and $9.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 6.14 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 2.46 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 3.58 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 1.72 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 815.44 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 5.10 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 1.71 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 811.99 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 544.80 Mn
10 Rezolute 477.02 Mn 477.02 Mn - 11.24 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 11.24 Mn
Dec 31, 2025 11.94 Mn
Sep 30, 2025 9.10 Mn
Jun 30, 2025 94.11 Mn
Mar 31, 2025 14.60 Mn
Dec 31, 2024 8.93 Mn
Sep 30, 2024 10.50 Mn
Jun 30, 2024 70.40 Mn
Mar 31, 2024 5.93 Mn
Dec 31, 2023 12.50 Mn
Sep 30, 2023 8.10 Mn
Jun 30, 2023 16.04 Mn
Mar 31, 2023 33.74 Mn
Dec 31, 2022 146.75 Mn
Sep 30, 2022 154.32 Mn
Jun 30, 2022 150.41 Mn
Mar 31, 2022 63.42 Mn
Dec 31, 2021 77.40 Mn
Sep 30, 2021 37.30 Mn
Jun 30, 2021 41.05 Mn